CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

mrna-1273

Trade name: Spikevax

VaccineexperimentalCOVID-19

Clinical trial activity

95 trials · 129 clinical orgs · 0 marketing orgs

Phase 1
12
Phase 2
51
Phase 3
29
Phase 4
22

Earliest trial started Mar 19, 2020 (NCT04283461)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07279766Phase 4Dec 11, 2025Moderna Therapeutics, University of Copenhagen
NCT06599658Phase 2Nov 20, 2024McGill University
NCT06634797Phase 4Oct 8, 2024Moderna Therapeutics
NCT06633835Phase 4Sep 20, 2024Novavax, University of Utah
NCT06503900Phase 4Sep 12, 2024Boston University, Centers for Disease Control and Prevention (CDC), Duke University, Emory University, Wake Forest University
NCT06585241Phase 4Sep 9, 2024Moderna Therapeutics
NCT06354998Phase 3Apr 8, 2024Moderna Therapeutics
NCT06441955Phase 4Mar 1, 2024Well- Konnect Healthcare Services and Research Firm
NCT06038617Phase 4Oct 30, 2023Centers for Disease Control and Prevention (CDC), Columbia University, Duke University, Kaiser Permanente, University of Cincinnati
NCT06020118Phase 4Sep 25, 2023Arizona State University, Case Western Reserve University, Centers for Disease Control and Prevention (CDC), Duke University, University of Pittsburgh, Valleywise Health, Washington University in St. Louis
NCT05672355Phase 2Aug 1, 2023City of Hope National Medical Center, National Cancer Institute (NCI)
NCT05827926Phase 1/Phase 2 (Phase 2)Apr 14, 2023Moderna Therapeutics
NCT05815498Phase 3Mar 28, 2023Moderna Therapeutics
NCT05543356Phase 3Feb 28, 2023Coalition for Epidemic Preparedness Innovations, Murdoch University, The Peter Doherty Institute
NCT05387317Phase 3Feb 28, 2023Coalition for Epidemic Preparedness Innovations, Government of Indonesia, Murdoch University, Padjadjaran University, The Peter Doherty Institute, University of Indonesia
NCT05585632Phase 1Oct 14, 2022Moderna Therapeutics
NCT05556720Phase 3Oct 1, 2022Monash University
NCT05584202Phase 2Sep 30, 2022Moderna Therapeutics
NCT05383560Phase 2Sep 5, 2022Moderna Therapeutics, Tel Aviv University
NCT05465902Phase 2Jul 31, 2022Government of China
Showing 20 of 95 trials
Page 1 / 5

Organizations

Research & Development (129)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Moderna TherapeuticsFor profit242042020
National Institute of Allergy and Infectious Diseases (NIAID)Government131042020
Duke UniversityAcademic/Hospital5422021
Johns Hopkins UniversityAcademic/Hospital5032021
Centers for Disease Control and Prevention (CDC)Government4012021
Coalition for Epidemic Preparedness InnovationsAcademic/Hospital4022022
Assistance Publique - Hôpitaux de ParisAcademic/Hospital3332021
Department of Health and Human ServicesGovernment3022020
Murdoch UniversityAcademic/Hospital3312022
Sinocelltech Ltd.For profit3322022
Tel Aviv UniversityAcademic/Hospital3332021
The Peter Doherty InstituteAcademic/Hospital3012022
University of CopenhagenAcademic/Hospital3212021
University of GroningenAcademic/Hospital3222021
University of TorontoAcademic/Hospital3232021
Emory UniversityAcademic/Hospital2022021
Erasmus University RotterdamAcademic/Hospital2122021
Harvard UniversityAcademic/Hospital2022021
Laval UniversityAcademic/Hospital2022021
Leiden UniversityAcademic/Hospital2122021
129 organizations
Page 1 / 7